SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-21-006236
Filing Date
2021-03-17
Accepted
2021-03-16 21:58:21
Documents
67
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20201231_10k.htm 10-K 932972
2 EXHIBIT 21.1 ex_234335.htm EX-21.1 6359
3 EXHIBIT 23.1 ex_234411.htm EX-23.1 3220
4 EXHIBIT 31.1 ex_234412.htm EX-31.1 14964
5 EXHIBIT 31.2 ex_234413.htm EX-31.2 14892
6 EXHIBIT 32.1 ex_234414.htm EX-32.1 8199
13 dffn20201231_10kimg001.gif GRAPHIC 6957
14 dffn20201231_10kimg003.gif GRAPHIC 48769
15 dffn20201231_10kimg004.gif GRAPHIC 65611
16 dffn20201231_10kimg005.gif GRAPHIC 24731
17 dffn20201231_10kimg006.gif GRAPHIC 23739
18 rider.jpg GRAPHIC 59720
  Complete submission text file 0001437749-21-006236.txt   4252982

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT dffn-20201231.xml EX-101.INS 587716
8 XBRL TAXONOMY EXTENSION SCHEMA dffn-20201231.xsd EX-101.SCH 46270
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20201231_cal.xml EX-101.CAL 35060
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20201231_def.xml EX-101.DEF 297266
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20201231_lab.xml EX-101.LAB 269207
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20201231_pre.xml EX-101.PRE 322600
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 21748270
SIC: 2834 Pharmaceutical Preparations